Objective: Prevention trials for neurodegenerative diseases use genetic or other risk marker tests to select... http://t.co/v7FEkQA8iL
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/uI7EIDbFLB #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/rBYQbudYZ6 #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/qLgMDj8teQ #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/CCYp968Svf #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/fXSAO8iu67 #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/NiUayx5hFq #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/0VdgKoYtVz #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/uI7EIDbFLB #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials http://t.co/we0J0urBxH #Biobanking
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.: Ethics of ge... http://t.co/DUV3zkw7EY